Hangzhou AGS Medtech CoSHSE:688581 -0.89%87 Net Margin % is 40.44% as of Mar. 2026, which is 18% above its 10-year median of 34.31. GuruFocus rates SHSE:688581 with a GF Score™ of 87/100 and a GF Value™ of ¥74.30 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Hangzhou AGS Medtech Co ranks better than 97.55% on this metric.
The historical rank and industry rank for Hangzhou AGS Medtech Co's Net Margin % or its related term are showing as below:
SHSE:688581'
s Net Margin % Range Over the Past 10 Years
Min: -21.72 Med: 34.31 Max: 46.09
Current: 36.7
SHSE:688581's Net Margin % is ranked better than 97.55% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.06
vs SHSE:688581: 36.70
Hangzhou AGS Medtech Co (SHSE:688581) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Hangzhou AGS Medtech Co Net Margin % Related Terms
Hangzhou AGS Medtech Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688581 vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Hangzhou AGS Medtech Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hangzhou AGS Medtech Co Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hangzhou AGS Medtech Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Hangzhou AGS Medtech Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hangzhou AGS Medtech Co (SHSE:688581) has a Net Margin % of 40.44% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Hangzhou AGS Medtech Co and its competitors. This is 18% above median its historical median of 34.31. According to the industry distribution chart, Hangzhou AGS Medtech Co ranks #20 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 2.5%.
Is Hangzhou AGS Medtech Co's Net Margin % too high?
Hangzhou AGS Medtech Co's current Net Margin % of 40.44% is 18% above median its 10-year median of 34.31. The Medical Devices & Instruments industry median Net Margin % is 2.06. Hangzhou AGS Medtech Co's value of 40.44% is 1863.1% above this industry median. Based on the distribution chart, Hangzhou AGS Medtech Co ranks #20 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Hangzhou AGS Medtech Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hangzhou AGS Medtech Co's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Hangzhou AGS Medtech Co ranks #20 out of 816 companies for Net Margin %. This places Hangzhou AGS Medtech Co in the top 3% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.06. Hangzhou AGS Medtech Co's value of 40.44% is 1863.1% above this benchmark. While the company's 10-year median is 34.31 vs. the industry median of 2.06, Hangzhou AGS Medtech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.06, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hangzhou AGS Medtech Co's current Net Margin % of 40.44% is 1863.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Hangzhou AGS Medtech Co and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hangzhou AGS Medtech Co's current Net Margin % is 40.44%, which is 18% above median its own 10-year median of 34.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hangzhou AGS Medtech Co stock overvalued right now?
Based on GuruFocus' analysis, Hangzhou AGS Medtech Co (SHSE:688581) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥74.30, compared to a current price of ¥55.70 — trading 25% below its estimated fair value. The current Net Margin % is 40.44%, which is 18% above median its 10-year median of 34.31 and 1863.1% above the Medical Devices & Instruments industry median of 2.06. Hangzhou AGS Medtech Co's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Hangzhou AGS Medtech Co (SHSE:688581), the current Net Margin % is 40.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hangzhou AGS Medtech Co (SHSE:688581) Overvalued in 2026?
Based on GuruFocus' analysis, Hangzhou AGS Medtech Co stock appears to be undervalued.
The current stock price of ¥55.70 is trading 25% below its estimated GF Value™ of ¥74.30.
GuruFocus considers Hangzhou AGS Medtech Co to be Modestly Undervalued.
Key valuation signals for SHSE:688581:
Net Margin %: 40.44% (18% above median its 10-year median of 34.31)
GF Value™: ¥74.30 vs. price of ¥55.70 (25% below fair value)
Industry Position: 1863.1% above the Medical Devices & Instruments median (#20 of 816)
No single metric tells the full story. See the SHSE:688581 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and provide patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.
87GF Score
Get the complete analysis for SHSE:688581
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688581 has been successfully added to your 
